These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34533265)

  • 1. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.
    Pedrazini MC; da Silva MH
    Dermatol Ther; 2021 Nov; 34(6):e15129. PubMed ID: 34533265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-lysine therapy to control the clinical evolution of pityriasis rosea: Clinical case report and literature review.
    Pedrazini MC; Groppo FC
    Dermatol Ther; 2021 Jan; 34(1):e14679. PubMed ID: 33326128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pityriasis Rosea after COVID-19 Infection.
    Prtajin M; Ljubojević Hadžavdić S
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
    Cohen OG; Clark AK; Milbar H; Tarlow M
    Hum Vaccin Immunother; 2021 Nov; 17(11):4097-4098. PubMed ID: 34435935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination.
    Leerunyakul K; Pakornphadungsit K; Suchonwanit P
    Front Med (Lausanne); 2021; 8():752443. PubMed ID: 34557507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.
    Buckley JE; Landis LN; Rapini RP
    JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestational Pityriasis Rosea: Suggestions for Approaching Affected Pregnant Women.
    Monastirli A; Pasmatzi E; Badavanis G; Tsambaos D
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):312-313. PubMed ID: 28128088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pityriasis Rosea Eruption Following the Administration of Oxford-AstraZeneca Vaccine.
    Marghalani S; Alghamdi Y; Albrakati BA; Huwait HF; Mohanna AT
    Cureus; 2024 Mar; 16(3):e56310. PubMed ID: 38628985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
    Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
    Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature.
    Veraldi S; Boneschi V; Cusini M; Maronese CA
    Dermatol Reports; 2023 Mar; 15(1):9503. PubMed ID: 37063394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
    Wang CS; Chen HH; Liu SH
    J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of pityriasis rosea-like drug eruption secondary to imatinib: A case report and review of the literature.
    Durgin JS; Whittington CP; Harrell J; Mervak JE; Smith EH
    J Cutan Pathol; 2024 Nov; 51(11):860-865. PubMed ID: 39021288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman.
    Al Hatmi I; Al Maqbali H; Al Waily A; Al Khalili A; Qureshi A
    Oman Med J; 2023 Nov; 38(6):e579. PubMed ID: 38264510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
    Valk B; Bender B
    Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pityriasis rosea like eruption: A dermatological manifestation of Coronavac-COVID-19 vaccine.
    Gökçek GE; Öksüm Solak E; Çölgeçen E
    Dermatol Ther; 2022 Feb; 35(2):e15256. PubMed ID: 34881483
    [No Abstract]   [Full Text] [Related]  

  • 16. Pityriasis Rosea: An Updated Review.
    Leung AKC; Lam JM; Leong KF; Hon KL
    Curr Pediatr Rev; 2021; 17(3):201-211. PubMed ID: 32964824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India.
    Mehta H; Handa S; Malhotra P; Patial M; Gupta S; Mukherjee A; Chatterjee D; Takkar A; Mahajan R
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e16-e18. PubMed ID: 34547126
    [No Abstract]   [Full Text] [Related]  

  • 18. Pityriasis rosea during omalizumab treatment for chronic spontaneous urticaria.
    Vaccaro M; Marafioti I; Cannavò SP; Ciccarese G; Drago F
    Dermatol Ther; 2020 Nov; 33(6):e14356. PubMed ID: 33009684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
    Wong N; Cascardo CA; Mansour M; Qian V; Potts GA
    Cureus; 2023 May; 15(5):e38772. PubMed ID: 37303403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
    Drago F; Broccolo F; Ciccarese G
    Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.